Poolbeg Pharma PLC (POLBF)
USD 0.15
(27.97%)
USD 0.15
(27.97%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.68 Million GBP | 6.02% |
| 2022 | -4.98 Million GBP | -113.44% |
| 2021 | -2.33 Million GBP | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -2.26 Million GBP | -216894.72% |
| 2023 FY | -5.04 Million GBP | -1.12% |
| 2023 Q4 | -1301.50 GBP | 0.0% |
| 2023 Q3 | -1301.50 GBP | 99.94% |
| 2023 Q1 | -1041.50 GBP | 99.97% |
| 2022 Q2 | -1.88 Million GBP | -215082.65% |
| 2022 FY | -4.98 Million GBP | -113.44% |
| 2022 Q4 | -3.37 Million GBP | -208867.22% |
| 2022 Q3 | -1617.00 GBP | 99.91% |
| 2022 Q1 | -876.00 GBP | 0.0% |
| 2021 FY | -2.33 Million GBP | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Bioxytran, Inc. | -3.82 Million USD | -22.665% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 93.472% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -1690.422% |
| SQZ Biotechnologies Company | -75.82 Million USD | 93.82% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -64.392% |
| Evofem Biosciences, Inc. | -17.84 Million USD | 73.743% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 105.725% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -205.068% |
| Marizyme, Inc. | -34.08 Million USD | 86.253% |
| Genus plc | 6.4 Million USD | 173.219% |
| Pharming Group N.V. | -4.87 Million USD | 3.966% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -135.895% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -403.124% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | 43.88% |
| ContraFect Corporation | -56.88 Million USD | 91.763% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -234.239% |
| IMV Inc. | -38.67 Million USD | 87.883% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -70.348% |
| ONE Bio Corp. | 13.68 Million USD | 134.251% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 92.056% |
| Mesoblast Limited | -84.14 Million USD | 94.431% |
| MultiCell Technologies, Inc. | -722.81 USD | -648203.15% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 232.373% |
| Genscript Biotech Corporation | -415.79 Million USD | 98.873% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -1102.865% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -78.343% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 195.344% |
| Biomind Labs Inc. | -1 Million USD | -364.143% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -61.517% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | 29.513% |
| Skye Bioscience, Inc. | -13.67 Million USD | 65.725% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -151.345% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 148.099% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -15545.032% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -2.882% |
| Arch Therapeutics, Inc. | -5.04 Million USD | 7.106% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 70.472% |
| Accustem Sciences Inc. | -3.74 Million USD | -25.079% |
| EV Biologics, Inc. | -483.06 Thousand USD | -870.062% |
| Q BioMed Inc. | -3.44 Million USD | -35.999% |
| GB Sciences, Inc. | -1.42 Million USD | -229.882% |
| Alpha Cognition Inc. | -9.7 Million USD | 51.719% |
| CSL Limited | 3.7 Billion USD | 100.127% |
| Agentix Corp. | -1.37 Million USD | -241.606% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 91.476% |
| Enzolytics Inc. | -2.14 Million USD | -118.075% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Resverlogix Corp. | -12.74 Million USD | 63.244% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -47.904% |
| MetaStat, Inc. | - USD | Infinity% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -142.47% |
| argenx SE | -425.04 Million USD | 98.898% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 91.558% |
| HST Global, Inc. | -140.9 Thousand USD | -3225.598% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -348.851% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -316.568% |
| Halberd Corporation | -75.05 Thousand USD | -6143.837% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -60.51% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -37.622% |
| Zenith Capital Corp. | -8.94 Million USD | 47.601% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -196.703% |
| GeneThera, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -90.851% |
| AVAX Technologies, Inc. | 6.69 Million USD | 170.015% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -2632.21% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -133.744% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -26798.571% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Adynxx, Inc. | - USD | Infinity% |
| NovAccess Global Inc. | -2.46 Million USD | -89.966% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -376.194% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -273.089% |
| Kadimastem Ltd | -3.04 Million USD | -54.132% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| BioStem Technologies, Inc. | -7.77 Million USD | 39.761% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -2482.032% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -250.898% |
| LadRx Corporation | -3.82 Million USD | -22.554% |
| Cell Source, Inc. | -4.32 Million USD | -8.338% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -1027.855% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -582.146% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -582.146% |
| Affymax, Inc. | -15.04 Million USD | 68.856% |
| Mobile Lads Corp. | -554.55 Thousand USD | -745.009% |
| Itoco Inc. | -919.14 Thousand USD | -409.824% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -10.56% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -318.767% |
| International Stem Cell Corporation | -663 Thousand USD | -606.787% |
| CytoDyn Inc. | -18.05 Million USD | 74.05% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -18517.402% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -2029.245% |
| Qrons Inc. | -643.67 Thousand USD | -628.005% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -729.787% |
| SYBLEU INC | -149.18 Thousand USD | -3041.172% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.22 Million USD | -110.146% |
| Rebus Holdings, Inc. | -664 Thousand USD | -605.723% |
| GlobeImmune, Inc. | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -157.994% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -8801.976% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -22938.348% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | 87.079% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -189.617% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -536.828% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -50.627% |
| Neutra Corp. | -229.48 Thousand USD | -1941.955% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | 73.282% |
| PureTech Health plc | -146.19 Million USD | 96.795% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | 78.196% |
| IXICO plc | -1.43 Million USD | -226.096% |
| IntelGenx Technologies Corp. | -9.49 Million USD | 50.627% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 96.153% |
| CSL Limited | 3.81 Billion USD | 100.123% |
| Cellectis S.A. | -108.85 Million USD | 95.695% |